» Articles » PMID: 36347626

Clinical Reasoning: Rapidly Progressive Dementia in a Man With HIV Infection and Undetectable Plasma Viral Load

Overview
Journal Neurology
Specialty Neurology
Date 2022 Nov 8
PMID 36347626
Authors
Affiliations
Soon will be listed here.
Abstract

Neurocognitive decline associated with HIV infection remains prevalent even in the antiretroviral therapy (ART) era, albeit usually in less severe forms. The differential diagnosis of cognitive impairment in this population is quite broad, including infectious causes such as CNS opportunistic infections, causes directly related to HIV such as HIV-associated neurocognitive disorders, and causes entirely unrelated to HIV infection such as primary dementia syndromes. In this case report, a 47-year-old man with HIV on ART with an undetectable plasma viral load presented with rapidly progressive dementia to a clinic in Zambia. He had been functioning independently and fully employed before symptom onset but had to stop working within 2 months of symptom onset because of the severity and rapidity of his cognitive decline. Initial workup led to an empiric diagnosis and initiation of an empiric treatment regimen, which was ultimately ineffective. This prompted re-evaluation, additional workup, and, ultimately, discovering the correct diagnosis. This case highlights the stepwise approach to developing a diagnosis in a resource-limited setting where there exists a high burden of HIV infection, including the necessity of empiric diagnoses of treatment plans when investigations are limited and the importance of reconsidering these diagnoses in the face of additional clinical information. In addition, it highlights both infectious and noninfectious causes of cognitive decline in people with HIV.

References
1.
Mirgh S, Mishra V, Harbada R, Sorabjee J . Knowing the unknown - CD8 encephalitis: A novel form of HIV-associated neurocognitive disorder. Neurol India. 2019; 67(1):261-264. DOI: 10.4103/0028-3886.253630. View

2.
Harrington P, Schnell G, Letendre S, Ritola K, Robertson K, Hall C . Cross-sectional characterization of HIV-1 env compartmentalization in cerebrospinal fluid over the full disease course. AIDS. 2009; 23(8):907-15. PMC: 3089803. DOI: 10.1097/QAD.0b013e3283299129. View

3.
Peluso M, Ferretti F, Peterson J, Lee E, Fuchs D, Boschini A . Cerebrospinal fluid HIV escape associated with progressive neurologic dysfunction in patients on antiretroviral therapy with well controlled plasma viral load. AIDS. 2012; 26(14):1765-74. PMC: 3881435. DOI: 10.1097/QAD.0b013e328355e6b2. View

4.
Ellis R, Badiee J, Vaida F, Letendre S, Heaton R, Clifford D . CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy. AIDS. 2011; 25(14):1747-51. PMC: 3867631. DOI: 10.1097/QAD.0b013e32834a40cd. View

5.
Dravid A, Gawali R, Betha T, Sharma A, Medisetty M, Natrajan K . Two treatment strategies for management of Neurosymptomatic cerebrospinal fluid HIV escape in Pune, India. Medicine (Baltimore). 2020; 99(24):e20516. PMC: 7302684. DOI: 10.1097/MD.0000000000020516. View